discmedicine.comHealthcare / BioTech & PharmaFounded: 2017Funding to Date: $145MM
Disc Medicine is a biotech company developing treatments to help patients suffering from hematologic diseases.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
09/02/2021 | Series B | $90MM | $xx.xx | $253.72MM | 5am Ventures, Access Biotechnology, Alexandria Venture Investments, Arix Bioscience, Atlas Venture, Janus Henderson Investors, Nantahala Capital Management, Novo Holdings A/S, Orbimed, Rock Springs Capital, Willett Advisors | |
Price per Share
$xx.xx
Shares Outstanding
37,500,000
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Participating
Participation Cap
2.5
Key Investors
5am Ventures, Access Biotechnology, Alexandria Venture Investments, Arix Bioscience, Atlas Venture, Janus Henderson Investors, Nantahala Capital Management, Novo Holdings A/S, Orbimed, Rock Springs Capital, Willett Advisors
|
||||||
10/29/2019 | Series A | $50MM | $xx.xx | $93.33MM | Access Biotechnology, Atlas Venture, Novo Holdings A/S | |
Price per Share
$xx.xx
Shares Outstanding
41,666,666
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Participating
Participation Cap
2.5
Key Investors
Access Biotechnology, Atlas Venture, Novo Holdings A/S
|
||||||
10/11/2017 | Series Seed | $5MM | $xx.xx | $20MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
5,000,000
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Participating
Participation Cap
2.5
Key Investors
Undisclosed Investors
|